Schizophrenia patients treated with risperidone (unspecified dose, 50.1 ± 82.4 months) reduced plasma levels of adiponectin when compared with healthy subjects (145), and medication-free children showed a decrease in adiponectin levels after 16 weeks of treatment (3–91 months) (146). The gene discussed is ADIPOQ; the disease is schizophrenia.